Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Long-Term Investments: 2014-2021

Historic Long-Term Investments for Fortress Biotech (FBIO) over the last 8 years, with Sep 2021 value amounting to $56.9 million.

  • Fortress Biotech's Long-Term Investments rose 385.03% to $56.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $56.9 million, marking a year-over-year increase of 385.03%. This contributed to the annual value of $17.6 million for FY2020, which is 57.57% up from last year.
  • According to the latest figures from Q3 2021, Fortress Biotech's Long-Term Investments is $56.9 million, which was up 17.28% from $48.5 million recorded in Q2 2021.
  • Over the past 5 years, Fortress Biotech's Long-Term Investments peaked at $56.9 million during Q3 2021, and registered a low of $1.2 million during Q1 2017.
  • For the 3-year period, Fortress Biotech's Long-Term Investments averaged around $20.5 million, with its median value being $11.2 million (2019).
  • In the last 5 years, Fortress Biotech's Long-Term Investments plummeted by 41.03% in 2017 and then surged by 385.03% in 2021.
  • Over the past 5 years, Fortress Biotech's Long-Term Investments (Quarterly) stood at $1.4 million in 2017, then skyrocketed by 318.50% to $6.7 million in 2018, then spiked by 67.69% to $11.1 million in 2019, then surged by 57.57% to $17.6 million in 2020, then soared by 385.03% to $56.9 million in 2021.
  • Its Long-Term Investments was $56.9 million in Q3 2021, compared to $48.5 million in Q2 2021 and $23.5 million in Q1 2021.